Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dantrolene for Analgesia in Posterior Lumbar Surgery
NCT03762109Phase 2Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Jul 2019
- Primary completion
- Jun 2024
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Lumbar spine injury comparing Dantrolene Group with Placebo Oral Tablet Group (2 arms). Primary endpoint: Overall Benefit of Analgesia at 24 hours. Started Jul 2019; status: completed.
02
Drugs
dantrolene
03
Conditions
Lumbar spine injury
Beyond the preview
Go deeper on NCT03762109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03762109.